The question of what products and processes are eligible for patent protection, and in particular the scope of the exception for laws of nature, has been the subject of recent scrutiny in the Supreme Court and Federal Circuit. The panel will address the latest developments in patentable subject matter law regarding the patenting of isolated DNA molecules. Panelists will present recent case examples such as the Myriad Genetics case, Mayo Collaborative Services vs Prometheus Labs., Inc. case, and related developments in the courts and Congress that could affect the biotechnology industry.
- Review recent developments in the law of patentable subject matter
- Discuss BIO’s leadership role on the issue of patentable subject matter
- Engage in a spirited discussion of the implications of recent court decisions
Ability Level: All
Session ID: 1972